Multicenter clinical evaluation study of clinical effectivity of AptoDetectTM-Lung for Auxiliary diagnostics of Non-Small Cell Lung Cancer [Apto_RADS]

Kyung Hee University Hospital0 个研究点目标入组 2,994 人开始时间: 待定最近更新: 2023年1月10日

适应症

试验速览

暂无简介。

•1) A patient who has given written consent to participate in this study
•2) Adult men and women over 19 years of age
•3) Patients with solid nodules or part solid nodules corresponding to categories 3 to 4 according to the Lung-RADS® version 1.1 pulmonary nodule categorization guidelines
•However, patients in category S according to the Lung-RADS® version 1.1 pulmonary nodule categorization guidelines can also be enrolled.

•1) Patients with ground glass nodules (GGO) in the Lung-RADS® version 1.1 pulmonary nodule categorization guidelines
•2) Any pulmonary infection requiring current treatment (both oral or intravenous)
•However, if the researcher determines that treatment for lung infection has been completed, enrollment is possible.
•3) Patients with histologically confirmed malignant tumors prior to participation in this study
•However, registration is possible in the following cases, but registration is not possible if the patient is accompanied by a malignant tumor requiring current treatment.
•? Cases confirmed as malignant tumors (including lung cancer) but in remission for more than 5 years after completion of treatment
•? Effectively treated non-melanoma skin cancer, cervical carcinoma in situ, mammary ductal carcinoma in situ, localized prostate cancer treated for curative purposes, and thyroid cancer can be registered.
•4) Pregnant women

发起方

Kyung Hee University Hospital